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Abstract
Age-related hearing loss (ARHL) is the most common sensory disorder in the elderly. Although not directly life threatening,
it contributes to loss of autonomy and is associated with anxiety, depression and cognitive decline. To search for genetic risk
factors underlying ARHL, a large whole-genome sequencing (WGS) approach has been carried out in a cohort of 212 cases
and controls, both older than 50 years to select genes characterized by a burden of variants speciﬁc to cases or controls.
Accordingly, the total variation load per gene was compared and two groups were detected: 375 genes more variable in cases
and 371 more variable in controls. In both cases, Gene Ontology analysis showed that the largest enrichment for biological
processes (fold > 5, p-value= 0.042) was the “sensory perception of sound”, suggesting cumulative genetic effects were
involved. Replication conﬁrmed 141 genes, while additional analysis based on natural selection led to a prioritization of 21
genes. The majority of them (20 out of 21) showed positive expression in mouse cochlea cDNA and were associated with
two functional pathways. Among them, two genes were previously associated with hearing (CSMD1 and PTRPD) and re-
sequenced in a large Italian cohort of ARHL patients (N= 389). Results led to the identiﬁcation of six coding variants not
detected in cases so far, suggesting a possible protective role, which requires investigation. In conclusion, we show that this
multistep strategy (WGS, selection, expression, pathway analysis and targeted re-sequencing) can provide major insights
into the molecular characterization of complex diseases such as ARHL.
Introduction
Complex diseases are caused by several genetic and envir-
onmental factors, many of which still need further investi-
gation [1]. Moreover, in contrast to monogenic disorders
where causative genetic variants have near complete pene-
trance, complex diseases need speciﬁc approaches to be
further investigated. The difﬁculty of exploring complex
disease genetic models, lies in controlling the environmental
components on one hand and accounting for different
unknown genetic hypotheses on the other, such as pleio-
tropy, cumulative effects, gene–gene interactions etc. [2].
Age-related hearing loss (ARHL) or presbycusis is a very
common complex disease leading to hearing deﬁcits in the
elderly. Due to the ageing population in our society, ARHL
has reached to a 30% incidence among people over 50 years
of age [3], becoming a major health care problem world-
wide. ARHL signiﬁcantly decreases the autonomy of
affected people and also contributes to their anxiety,
depression, and cognitive decline [4, 5]. The hearing loss is
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progressive, starting from high frequencies and subse-
quently affecting medium and lower frequencies as well.
The cause is heterogeneous consisting of both environ-
mental and genetic factors, and, although we have a rea-
sonable understanding of the environmental risk factors, we
know little about the genetic factors [6].
In particular, ARHL is characterized by an uncertain her-
itability and a higher genetic heterogeneity compared with
other complex traits (i.e., diabetes, rheumatoid arthritis).
Thus, it is not surprising that, up to now, there was a dearth of
gene discovery despite some published Genome Wide
Association studies (GWAS) [7, 8]. Moreover, as genetic
data become available on a large scale, pleiotropy increas-
ingly becomes an interesting topic for complex and frequent
diseases such as ARHL. Variability in complex diseases, such
as ARHL, might be due to epigenetic changes during hair cell
development and regeneration. To date, the possible invol-
vement of epigenetic changes is still largely unknown and
future studies are needed to shed light on this mechanism.
Recently, the possibility of analyzing whole-genome
sequencing (WGS) and whole-exome sequencing (WES)
data at population level has been highlighted [9]. However,
it was shown that GWAS studies lose in power due to the
allele frequency spectrum targeted by sequencing with
realistic sample sizes [10]. Hence, it is necessary to explore
new methodologies and approaches when dealing with
WGS and WES data.
For the present work, WGS data for ARHL cases and
controls from villages located in North-Eastern Italy (total of
156 subjects) were available, as well as individuals from an
independent cohort of North-Western Italy, which was used
for replication (56 subjects). Given the high complexity and
genetic heterogeneity of the phenotype, we decided to
explore a new scenario under the hypothesis that several
variants contributing to the disease have a cumulative effect.
To achieve this goal, we deﬁned a pipeline characterized by
the following steps: (a) identiﬁcation of a burden of variants
in WGS data signiﬁcantly different among cases and controls,
(b) natural selection analysis of genes in order to detect genes
under selection, which can directly or indirectly inﬂuence the
phenotype, (c) expression studies in the inner ear and (d)
pathway analysis. Finally, to further validate our approach,
target re-sequencing screening was carried out in an addi-
tional cohort of 389 ARHL patients for two genes previously
reported as associated with hearing function in literature.
Materials and methods
Subjects
A WGS cohort of 378 individuals from the Friuli Venezia
Giulia region in North-Eastern Italy was selected strictly for
ARHL cases and controls based on the audiometric phe-
notype. A total of 156 subjects were considered for the
discovery set: 78 cases and 78 controls matched by sex
and age (mean age cases= 69, controls= 65; percentage of
female cases= 60%, controls= 63%). Following the same
selection criteria, a replication set of 56 subjects (28
cases and 28 controls) from an independent cohort located
in North-Western Italy, Piemonte region (original cohort
size n= 424) was enrolled, together with a completely
independent cohort of 389 cases coming from several
locations in Italy. Detailed demographic information
about all cohorts is reported in Supplementary Table 1.
Audiometric tests, a clinical examination and a lifestyle
questionnaire were carried out for each subject. Considering
that ARHL mainly affects hearing function at high fre-
quencies, 4 and 8 kHz were measured for each subject
and the average value was computed (pure tone average
high (PTAH)). To avoid non-genetic variations in the
hearing phenotype (e.g., monolateral hearing loss), the best
hearing ear was considered for each individual. Subjects
with history of occupational risk or pathologies related to
ARHL were excluded from the study. Cases were deﬁned as
people >50 years old having PTAH ≥ 40, whereas controls
were subjects >50 years old with PTAH ≤ 25. Blood sam-
ples were collected and DNA was extracted using a
phenol–chloroform extraction procedure. Considering pos-
sible substructure in the genetic background of our samples,
the overall genetic diversity (He) and inbreeding coefﬁcient
(Finbred) were estimated for cases and controls using
PLINK v1.07 [11]. The Mann–Whitney test was used to
evaluate the differences in these two statistics between the
two groups.
Whole-genome sequencing
Low coverage WGS data were generated using Illumina
technology (Genome Analyzer and HiSeq 2000) at the
Wellcome Trust Sanger Institute, Cambridge (UK) and
Beijing Genomics Institute, Shenzhen (China). Data cov-
erage ranged from 4× to 10×. Multi-sample genotype call-
ing was performed using Samtools mpileup (v. 1.2) [12] and
Variant Quality Score Recalibrator (VQSR) ﬁltering was
applied to the raw call data with GATK v.3.3 Varian-
tRecalibrator module [13], separately for single nucleotide
variants (SNVs) and insertions/deletions (INDELs). The
ﬁlter creates a Gaussian Mixture Model by looking at
annotation values over a high-quality subset of the input
call set and then evaluates all input variants. The following
parameters were used: for SNVs (I) Annotations: QD, DP,
FS, HaplotypeScore, MQRankSum, ReadPosRankSum,
InbreedingCoeff; (II) Training set: HapMap 3.3, Omni 2.5
M chip, 1000 Genomes Phase I; (III) Truth set: HapMap
3.3, Omni 2.5 M chip; (IV) Known set: dbSNP
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build 138; and for INDELs (a) Annotations: DP, FS,
ReadPosRankSum, MQRankSum; (b) Training set: Mills-
Devine, 1000 Genomes Phase I, dbSNP build 138; (c) Truth
set: Mills-Devine; (d) Known set: Mills-Devine, dbSNP
build 138. For each population, the lowest Variant Quality
Score Log Odds Ratio (VQSLOD) threshold was deter-
mined by the output produced by VariantRecalibrator to
select the best cut-off in terms of speciﬁcity and sensitivity
of the trained model. For single nucleotide polymorphisms
(SNPs), the selected minimum VQSLOD value was
−15.0283 (99.80% truth sensitivity threshold). As INDEL
calling and alignment is still more prone to error, a con-
servative approach was preferred, selecting a sensitivity
threshold of 95%. The ﬁlter has been applied using GATK’s
Apply Recalibration module.
To improve the quality of the raw genotyping results
based on the low coverage sequencing data, several geno-
type reﬁnement steps on the ﬁltered call set were performed:
(1) BEAGLEv4.r1230 [14] was used to assign posterior
probabilities to all remaining genotypes. (2) SHAPEITv2 to
phase all genotype calls [15] and (3) IMPUTEv2 [16] to
perform internal imputation in order to correct for geno-
typing errors. Information about the ancestral allele and
allele frequencies were retrieved from dbSNP build 138.
The data are available through the European Genome/Phe-
nome Archive (EGA) under the accession number
EGAD00001002014 (https://www.ebi.ac.uk/ega/datasets/
EGAD00001002014).
Data analysis
The complete workﬂow described below is summarized in
Fig. 1.
Outlier genes analysis
Following the standard VCF ﬁle format, a variant was
called if the alternative allele was present in at least one
subject from each group (cases and controls). The deﬁnition
of a gene was based on the Variant Effect Predictor v.74
[17] annotations and the number of variants was computed
for each gene separately for cases and controls. The number
of variants in controls was regressed with a linear regression
against the number of variants in cases. Outlier genes were
detected by selecting outlier residuals from the regression,
deﬁned as being >6 inter-quartile distances from the ﬁrst
and third quartile. For those genes, we separately analyzed
the upper and lower outliers as being signiﬁcantly more
mutated in cases than in controls (Group A) and vice versa
(Group B).
Statistical overrepresentation tests were carried out using
the web tool PANTHER version 10.0 [18] with the fol-
lowing Gene Ontology (GO) and PANTHER annotation
data sets: pathways, molecular function, biological process,
cellular component and protein class. Bonferroni correction
for multiple testing was applied. Results were compared
with 100 random overrepresentation tests on the same
number of randomly selected genes, in order to determine
any false-positive recurrent enrichment.
The same outlier detection protocol was conducted in the
replication cohort.
Variants classiﬁcation and distribution in cases and controls
To further investigate which variants were accumulated
in the outlier genes in cases and controls, respectively,
we annotated all the variants using ANNOVAR [19].
For simplicity, we divided variants in “exonic” and
“other”, grouping together the following annotations:
intronic, upstream, downstream, UTR3, UTR5, non-coding
RNA and splicing. We then compared variants present
only in cases and only in controls vs. those that were
shared.
Analyses of natural selection
The list of replicated genes was investigated for evidence of
possible adaptation applying a selection scan based on PCA
as described in Duforet-Frebourg et al. [20].
WGS
Comparison between cases and controls 
(outliers detected for variants load per gene)
Group A
N=375 genes 
showing more 
variants in 
cases
GO 
enrichment 
analysis
Replication
Independent cohort: 28 ARHL cases and 28 controls 
(Origin: North-West Italy)
141 genes confirmed 
Natural Selection Analysis 
African, European and East Asian pops. from 1kG
21 genes under positive selection
Expression in mouse 
cochlea: 
20 genes expressed + 
expression localization 
evaluated in public 
repositories
Pathway 
analysis: 
20 genes 
clustered in 2 
pathways
Target re-sequencing
2 genes previously 
associated with hearing
389 ARHL cases 
(Origin: Italy) 
2 putative protective 
variants detected
Group B
N=371 genes 
showing less 
variants in 
cases
Discovery Cohort: 
78 ARHL cases and 78 sex and age matched 
controls (Origin: North-East Italy)
Fig. 1 Workﬂow chart. The ﬁgure summarizes the workﬂow followed
and described in the article
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Considering that the analyzed cohorts were coming from
Northern Italy villages, only SNPs that were differentiated
along the European-Asian axis of variation (African, Eur-
opean and East Asian populations from 1000 Genome data)
were considered in this study (cut-off a false discovery rate
(FDR) of 0.1). Moreover, the derived allele frequency in the
European and Asian population groups for each signiﬁcant
SNP was calculated.
For all the analyses, the functions implemented in the R
package “pcadapt” have been used [21].
For each gene found under putative selection, we sear-
ched for any previous associations with other traits in the
GWAS catalog [22] (available at: www.ebi.ac.uk/gwas.
Accessed 30/08/2016), and we estimated the level of loss-
of-function (LoF) intolerance (pLI) from the Exac database
[23]. The closer pLI is to one, the higher the LoF intoler-
ance, that is, a gene with pLI >= 0.9 could be considered as
extremely LoF intolerant.
Pathway analysis
Genes under positive selection from the previous steps
underwent identiﬁcation of molecular network interactions
and pathway analysis using the Ingenuity Pathway Analysis
(IPA) tool by Ingenuity Systems (Redwood City, Cali-
fornia, USA; http://www.ingenuity.com). Only direct
interactions were taken into account and scores were com-
puted for constructed networks based on the likelihood of
the genes being connected together by random chance
(signiﬁcant threshold: score >2, with >99% conﬁdence).
Gene expression analysis
The expression of selected genes was tested in the inner ear
of CD-1 mice. Total RNA was extracted from the whole
cochleae of 2-month-old wild-type CD-1 mice using
Direct-zol RNA MiniPrep Kit (Zymo Research). RNA was
quantiﬁed using Nanodrop ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA). Com-
plementary DNAs were generated from 2 μg of total RNA
using the Transcriptor First Strand cDNA Synthesis Kit
(Roche) according to the manufacturer’s protocol. Com-
plementary DNAs (cDNAs) were used for semiquantitative
RT-PCR (sqRT-PCR). In all, 4 μl of cDNA were used for
PCR ampliﬁcation. Gene-speciﬁc primers spanning
exon–exon boundaries were designed (primer sequence
available upon request). β-Actin primers were used as
internal control. PCR reactions were optimized to 95°C for
2 min, 30 ampliﬁcation cycles at 95°C for 30 s, 60°C for 30
s, 72°C for 4 s and a ﬁnal extension of 1 min at 72°C using
Kapa HiFi HotStart ReadyMix PCR kit (Kapa Biosystem,
Cape town, South Africa). Ampliﬁed products were
resolved on 2% agarose gels and visualized by ethidium
bromide staining.
Targeted re-sequencing (TRS)
Two genes of interest were sequenced using the Ion Torrent
PGMTM (Life Technologies) platform. Genes were selected
based on the results from the data analyses described. A
total number of 389 ARHL cases were analyzed by TRS.
Brieﬂy, 10 ng of genomic DNA from whole peripheral
blood was used to construct DNA libraries using the Ion
AmpliSeq Library Kit 2.0 (Life Technologies, CA, USA),
according to the manufacturer’s protocols. Template Ion
Sphere Particles were prepared using the Ion PGM Tem-
plate OT2 200 kit and a single end 200 base-read sequen-
cing run was carried out using the Ion PGM sequencing 200
kit v2 (Life Technologies, CA, USA), on Ion Torrent PGM
platform (Life Technologies, CA, USA). Sixty-four indexed
patients’ libraries were sequenced simultaneously on each
Ion 318 Chip. Sequencing data were then analyzed
according to the Ion Torrent SuiteTM v3.6; SNVs and
INDELs were collected into a standardized VCF version
4.1.
Sanger sequencing
Speciﬁc variants of interest mentioned throughout the text
were all conﬁrmed by direct Sanger sequencing on a 3500
Dx Genetic Analyzer (Life Technologies, CA, USA), using
ABI PRISM 3.1 Big Dye terminator chemistry (Life
Technologies, CA, USA) according to the manufacturer’s
instructions.
Results
Discovery set analysis
Cases and controls analyzed in our cohort were genetically
homogeneous because no differences were found in
genome-wide observed heterozygosity (Mann–Whitney
Table 1 Summary information of variants detected in cases and
controls
Cases Controls
Overall number of coding and non-coding
variants
12,600,177 12,518,899
Median number of variants per gene 112 111
1st quartile (number of variants per gene) 49 49
3st quartile (number of variants per gene) 279 276
Mean number of variants per gene 281.1234 278.9673
Standard deviation 1003.006 997.2283
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p-value > 0.13) and inbreeding coefﬁcient (Mann–Whitney
p-value > 0.52).
In order to estimate differences in numbers of variants
per gene between cases and controls, a linear regression
analysis was performed. As reported in Table 1, the number
of variants varied greatly among genes. The linear regres-
sion showed great consistency, with data following the
diagonal line almost perfectly (regression line coefﬁcient=
0.9938 and R2 = 0.9992). After selecting outliers using
stringent criteria, a total of 746 genes were shortlisted with
signiﬁcantly more variants in cases than in controls (Group
A, total of 375 genes) or signiﬁcantly less variants in cases
than controls (Group B, total of 371 genes). Complete lists
of genes are reported in Supplementary Table 2. In Group
A, overrepresentation tests of GO highlighted 45 signiﬁcant
biological/molecular processes for which our list of genes
was enriched (Fig. 2). Regarding Group B, a total of 65
processes were signiﬁcantly enriched, 18 of which were
overlapping with those from Group A (Supplementary
Table 3 and Fig. 3). Interestingly, in both groups, the
“sensory perception of sound” biological function category
was the most enriched among all categories (fold enrich-
ment > 5).
Variants classiﬁcation and distribution in cases and
controls
Among the 746 outlier genes, we compared the distribu-
tions of exonic (i.e., coding) variants with the non-coding
ones. A Wilcoxon test showed a signiﬁcant increase of the
proportion of exonic variants detected in cases only com-
pared with the proportion of exonic variants in the set of
shared variants in Group A (p~2e-10, Fig. 4a), whereas the
proportions of non-coding variants were equally distributed
(p > 0.05, Fig. 4b). On the other hand, Group B genes were
not enriched for exonic variants detected only in controls
(Figs. 4c, d).
Replication
The same protocol was used to replicate data in a com-
pletely independent cohort with another Italian geographic
area (i.e., to overcome any confounding factors due to
population structure or relatedness) [24]. Overall, 141 genes
(57 out of 375 genes from Group A and 84 out of 371 from
Group B) have been replicated (see Supplementary
Table 2). In particular, 28,353 out of 149,798 variants
detected in the 57 replicated genes in Group A were only
present in cases. The vast majority of them (96 %) were
intronic or intergenic variants, whereas the remaining 4%
(1003 variants) were annotated as upstream, downstream,
UTR3, UTR5, ncRNA or exonic variants (i.e., on average
7.5 alleles in each patient, and 6 alleles per gene).
Regarding the 84 genes from Group B, 39,065 out of
224,384 variants were mainly intronic or intergenic (91%)
and only present in controls. The remaining 9% of func-
tionally relevant variants were present on average with 30
alleles per subject and 6 alleles per gene. Moreover, we
found three genes with homozygous variants in cases only:
KCNIP4, MAST, and TIAM1. Interestingly, the patient
carrying the TIAM1 homozygous variant is a 66 y.o. ARHL
male showing a severe hearing loss at PTAH (102.5 dB).
The variant is an exonic variant, rs34882418
(NM_003253.2:c.326C>T, NP_003244.2:p.(Thr109Ile))
predicted to be deleterious by SIFT, not present in the
ClinVar database and extremely rare in the 1000 Genomes
database (minor allele frequency= 0.005).
Analyses of natural selection
Analysis of natural selection has been carried out to test if
any of the 141 replicated genes could have been selected for
having a major role on phenotypes directly or indirectly
related to hearing. Moreover, we searched for evidence of
possible adaptation along the European-East Asian axis.
Twenty-one genes out of 141 (15%) were found to be under
selection (13 from Group B and 8 from Group A) (see
Table 2). Assessing LoF intolerance, a parameter to eval-
uate genes’ sensitivity to highly damaging variants, we
identiﬁed two genes from Group A and seven genes from
Group B that showed a probability of LoF intolerance (pLI)
> 0.9, which means that they did not tolerate the presence of
LoF alleles (see Table 2). Interestingly, all genes found to
be under selection were also present in the GWAS catalog
(i.e., already associated with a speciﬁc phenotype). One
very promising candidate gene is SDK1, which has been
already associated with vestibular phenotypes (i.e., motion
sickness) and it also seemed to be very important for
synapse formation/function and inner ear development
(Table 2).
Pathway analysis of genes under selection
Finally, the 21 genes under selection have been investigated
using IPA software in order to verify if they belong to any
known pathway. Results showed two pathways, each
including 10 focus molecules from our list of genes under
selection. In particular, the ﬁrst pathway (cell death and
survival, nervous system development and function, tissue
morphology, score= 24) contains the genes ATP8A2 and
PDE4D that have been already reported as expressed in the
inner ear or involved in the hearing system [25, 26].
The second pathway (post-translational modiﬁcation,
cardiovascular system development and function, cell
morphology, score= 24) contains, among others, four
candidates CSDM1, MYO1D, NRG1 and PTPRD, which
Whole-genome sequencing reveals new insights into age-related hearing loss: cumulative effects... 1171
Fig. 2 Enrichment analysis results. The ﬁgure displays enrichment
analysis results for Group A genes, highlighting overlaps in terms of
shared genes. The numbers indicate the number of genes listed for
each feature. The following data sets were analyzed and are displayed
separately: a molecular function; b biological process; c protein class;
d cellular component
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have been previously detected to have a role in the hearing
system and/or function [8, 27, 28].
Expression analysis
Expression analysis of the 21 strongly suggestive genes
under selection was performed in the inner ear of 2-month-
old mice. mRNA levels were normalized relative to the β-
actin (Fig. 5). Interestingly, data analysis revealed positive
expression for 20 genes (all but Dgki), suggesting a possible
role in the auditory system. In order to broadly evaluate
expression localization in the mouse inner ear, three pub-
licly available resources were consulted: SHIELD, MGI and
Gear (web resources). Results conﬁrmed some level of
expression for all the genes analyzed and all but three were
expressed in hair cells of the cochlea. The Dgki gene, not
detected in our experiments, was reported as weakly
expressed in surrounding cells of the cochlea and of the
vestibular system, as well as in auditory neurons. Detailed
information is provided in Supplementary Table 4.
TRS ARHL cohort
Two of the genes (CSMD1 and PTPRD) from Group B and
detected in the second IPA were previously described in
two studies performed by our group, focusing on GWAS
and replication in European and Asian samples. After sta-
tistical validation, both of them were investigated by
immunocytochemistry in mouse cochlea and showed dis-
tinctive expression patterns [27] strongly suggesting a
functional involvement in the auditory system. Based on
this previous knowledge and experience in investigating
these genes, we further prioritized them for performing
target re-sequencing in a very large independent cohort of
389 ARHL cases. We focused on the 10 exonic variants
(ﬁve for each gene) that we already detected only in con-
trols in our discovery step. Six of them (three out of ﬁve for
each gene, nonsynonymous and never reported in the 1000
Genomes and ESP databases) were not present in this large
cohort (Table 3), thus suggesting a possible protective role
to be further investigated.
Fig. 3 Overlap of enriched features between cases and controls. The ﬁgure summarizes all enriched features detected for Group A and Group B
genes, showing which are in common between the two groups
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Discussion
ARHL is a complex and heterogeneous disorder. Despite
all the efforts made in gene discovery, little is still known
about the genetic risk factors underlying the disease
itself. In this light, identifying cumulative and polygenic
effects involved in this disease is a big challenge. In
this study, we conducted a WGS analysis in a large
cohort of ARHL cases and healthy controls to identify
genes and variants involved in ARHL. In particular, we
showed that the strength of our approach relies on a novel
strategy to query WGS data that is not based on association
analysis. This strategy allowed us to identify genes enriched
in several relevant biological and molecular processes such
as “sensory perception of sound” (i.e., strictly connected
with the phenotype investigated) or “neurological system
development”. These ﬁndings might play an important
role in ARHL and hearing function, considering that the
hearing system is connected to the brain via the cochlear
nerve, and most of the hearing genes are expressed in the
brain [29]. Given that genes were selected for a differential
burden of variants between the two groups (cases or con-
trols), the presence of functional enrichment is evidence
of polygenic and cumulative effects involved in ARHL.
Accordingly, we demonstrated that case-speciﬁc exonic
variants were signiﬁcantly enriched, further suggesting
that an accumulation of coding variants might contribute
to the pathogenicity of a complex disease such as ARHL.
Of course in the future, attention should be paid to reg-
ulatory elements, which might also contribute to the phe-
notype similar to what has been described for other complex
diseases [30].
Fig. 4 Distributions of coding and non-coding variants. The ﬁgure
shows different distributions of coding and non-coding variants per
gene. To overcome differences in gene size, only proportions of the
total number of variants are shown: a Group A coding variants present
in cases only (red line) compared with variants shared between cases
and controls (black line); b Group A non-coding variants present in
cases only (red line) compared with those shared between cases and
controls (black line); c Group B coding variants present in cases only
(red line) compared with those shared between cases and controls
(black line); d Group B non-coding variants present in cases only (red
line) compared with those shared between cases and controls (black
line)
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Considering the difﬁculties underlying genetic replication
studies (e.g., due to different population structure), the high
replication rate of our strategy (i.e.,19%) further conﬁrms its
validity. The majority of replicated genes do not seem to be
under natural selection, which means they accumulated
variants in a neutral or relaxed fashion. This is in line with
other genes associated with complex traits, which display an
excess of negative selection [31]. This ﬁnding is also con-
sistent with data showing that the hearing phenotype and
related genes, such as Connexins, are affected by both
assortative mating and relaxed purifying selection [32–34].
Nevertheless, a subset of these genes (21 out of 141) was
estimated to be under natural selection. They were already
present in the GWAS catalog, thus being associated with
other phenotypes (i.e., not hearing) suggesting the presence
of pleiotropy. Expression studies revealed that most of these
genes were expressed in the inner ear.
The usefulness of our approach is further corroborated
by the following examples. First, genes under selection
in Group A should likely be those having stronger
effects. Accordingly, a predicted deleterious homozygous
variant in TIAM1 gene was detected in a patient, whose
audiometric phenotype was the severest among all cases
investigated. Most likely, the presence of this allele
might be enough to explain the phenotype in this patient
resembling a monogenic form of hearing loss. This agrees
with recent results showing a continuum of effect sizes
ranging from extremely rare variants driving Mendelian
disorders to common variants with small effects involved
in complex forms of the phenotype [35]. Moreover, TIAM1
is involved in regulating tissue polarity of hair cells by
interacting with the LIS1 gene [36] and it also shows a high
LoF intolerance (pLI= 1) further suggesting a possible
pathogenic role.
Table 2 Natural selection positive results with pLi and GWAS catalog associations for each gene
Gene Group SNPs with higher
DAF in
Probability of LOF
intolerance
GWAS catalog association
ATP8A2 B Europe 0.00 Eating disorders, bipolar disorder schizophrenia
FGF14 B East Asia 0.72 Preeclampsia, QT interval
SEMA6D B Europe, East Asia 1.00 Hair graying, Post bronchodilator FEV1/FVC ratio, BMI
MYO1D B Europe, East Asia 0.00 Refractive error
SLC8A1 B Europe 0.99 QT interval
SH3RF3 B Europe 0.98 facial and scalp hair features
KCNH7 B Europe 0.98 Psoriasis, inﬂammatory skin disease
PDE4D B East Asia 0.98 Breast cancer, asthma, immune response to smallpox vaccine (IL-6),
esophageal cancer
GRIK2 B Europe, East Asia 0.99 Biochemical measures
WBSCR17 B Europe 0.10 Response to montelukast in asthma (change in FEV1), response to
angiotensin II receptor blocker therapy
CSMD1 B Europe, East Asia n.a Menarche (age at onset), schizophrenia
NRG1 B Europe, East Asia 0.95 Thyroid hormone levels, thyroid cancer, Hirschsprung disease
PTPRD B Europe, East Asia 1.00 Immune response to measles-mumps-rubella vaccine,T2D, restless legs
syndrome
ANTXR1 A Europe, East Asia 0.99 Height
SDK1 A East Asia 0.01 Motion sickness, cognitive decline rate in late mild cognitive impairment,
quantitative traits
DGKI A Europe 0.74 BMI, schizophrenia, cognitive decline (age-related), AIDS progression
KIAA1217 A Europe 0.01 Cognitive performance, 3-hydroxy-1-methylpropylmercapturic acid levels
in smokers
DLG2 A East Asia 0.67 Mild inﬂuenza (H1N1) infection, Wilms tumor, inﬂuenza A (H1N1)
infection
WWOX A Europe 0.00 Pulmonary function, 3-hydroxy-1-methylpropylmercapturic acid levels in
smokers
SNX29 A Europe 0.00 Visceral adipose tissue adjusted for BMI, schizophrenia, symmetrical
dimethylarginine levels
TIAM1 A East Asia 1.00 Hypertension, amyotrophic lateral sclerosis
SNPs with higher DAF in SNPs with higher derived allele frequency in, Probability of LOF intolerance (pLi) probability of loss-of-function
intolerance: we consider pLI >= 0.9 as an extremely LoF intolerant set of genes, GWAS catalog association phenotype previously associated with
the gene by means of gwas
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The second example is related to genes under selection
from Group B. Two of them, CSMD1 [37, 38] and PTPRD
[39], were previously associated with other phenotypes.
More recently, they were associated with the hearing
function [8, 27] and replicated in a trans-ethnic cohort.
Expression proﬁles in mouse cochlea by immunocy-
tochemistry showed striking patterns suggesting a role in
hearing function [27]. Building on this previous knowledge,
a TRS study in a series of ARHL patients is reported
identifying six variants with a possible protective role for
ARHL and conﬁrming the pleiotropic effect of genes under
selection.
Regarding genotype–phenotype correlation, further
functional experiments (i.e., immunohistochemistry and
confocal experiments) to determine the exact localization
and the role of the gene/proteins identiﬁed will possibly
lead to a speciﬁc correlation between the audiometric
proﬁle and the relative gene. All these results highlight the
complexity of the hearing phenotype, its polygenic nature,
and the likely effects of genetic variation in the affected
patients.
Conclusions
Following the hypothesis of cumulative effects of several
variants contributing to the disease, we identiﬁed a list of
candidate genes for ARHL by applying a new strategy
based on different complementary approaches using WGS
data. In conclusion, this study provides a list of 21 candidate
genes, identiﬁed due to a differential mutational burden in
ARHL cases and controls, with evidence of natural
selection and expression in mouse cochlea. The molecular
screening of these candidates in larger cohorts of cases and
controls could be included in future NGS approaches for the
identiﬁcation of genetic risk factors and their individual
contribution to the etiology of ARHL and to further
understand how they interact with each other. Moreover,
strong evidence of a possible role in the disease was
obtained for two genes (i.e., CSMD1 and PTPRD) and a
series of variants detected in their sequences. These ﬁndings
underline the need for additional functional studies of both
CSMD1 and PTPRD genes/variants (e.g., in animal models)
to deﬁnitively prove their role in ARHL. Identifying
genetics risk factors for ARHL and improving appropriate
interventions will be a worthwhile goal for future research
and results presented in this article will be a valuable
starting point.
Web resources
MGI: http://www.informatics.jax.org/ [accessed November
2017];
SHIELD: https://shield.hms.harvard.edu/ [accessed
November 2017];
g-EAR: http://gear.igs.umaryland.edu/ [accessed
November 2017].
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Fig. 5 Expression proﬁles of
genes under natural selection.
The ﬁgure displays gene
expression for 21 genes detected
under natural selection,
normalized to beta-actin: a
sqRT-PCT on cDNA cochlea of
adult mice; b agarose gel bands
quantiﬁcation. All genes, apart
from one (DGKI) show good
levels of expression
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